News from LabRulezLCMS Library - Week 15, 2026

<p><strong>Traditional protein purification workflows in many laboratories still rely on ultracentrifugation and long incubation steps. These approaches often involve multi-step protocols, extended processing times, and the use of specialized equipment. As a result, workflows can become complex, time-consuming, and prone to variability.</strong></p><p>Magnetic bead-based protein purification offers a faster, simpler, and more efficient alternative by enabling selective capture and rapid magnetic separation.</p><h3><strong>Limitations of Conventional Protein Cleanup Methods</strong></h3><p><strong>In standard laboratory workflows, protein cleanup typically involves:</strong></p><ul><li>Multiple processing steps</li><li>Centrifugation and column equilibration</li><li>Dependence on specialized instrumentation</li><li>Long processing times</li></ul><p><strong>These factors introduce several challenges:</strong></p><ul><li>Increased complexity of workflows</li><li>Variability between runs, reducing reproducibility</li><li>Risk of sample loss during transfers, especially for small sample volumes or scarce targets</li><li>Limited throughput due to manual handling</li></ul><h3><strong>Principle of Magnetic Bead-Based Purification</strong></h3><p>Magnetic beads enable selective protein capture through surface functionalization.</p><p>Each bead is coated with <strong>streptavidin</strong>, allowing the attachment of a <strong>biotinylated ligand</strong>. This ligand can be selected based on the target analyte and may include:</p><ul><li>Antibodies</li><li>Aptamers</li><li>Antigen fragments</li></ul><p>This functionalization step provides the beads with the specificity required to bind the target analyte.</p><h3><strong>Materials and Key Components</strong></h3><h4><strong>Magnetic Beads</strong></h4><ul><li>Streptavidin-coated surface</li><li>Functionalized with biotinylated ligands</li></ul><h3><strong>Ligands</strong></h3><ul><li>Selected for target specificity</li><li>Attached to beads prior to purification</li></ul><h3><strong>Step-by-Step Procedure</strong></h3><h4><strong>1. Bead Activation</strong></h4><p>Load the biotinylated ligand onto the streptavidin-coated magnetic beads to confer specificity.</p><h4><strong>2. Washing</strong></h4><p>Remove impurities after ligand loading to prepare the beads for interaction with the sample.</p><h4><strong>3. Incubation with Sample</strong></h4><p>Incubate the functionalized beads with the sample to allow binding between the ligand and the target analyte.</p><h4><strong>4. Magnetic Separation</strong></h4><p>Place the sample on a magnet:</p><ul><li>Magnetic beads (with bound analyte) are attracted to the vessel wall</li><li>The liquid phase can be separated easily</li></ul><h4><strong>5. Washing</strong></h4><p>Wash the beads while they remain immobilized by the magnetic field to remove:</p><ul><li>Weak interactions</li><li>Non-specific binding</li></ul><h4><strong>6. Elution</strong></h4><p>Add an elution solvent to release the purified analyte from the beads.</p><h3><strong>Downstream Applications</strong></h3><p>After elution, the purified sample is ready for further analysis, including:</p><ul><li>LC-MS</li><li>Western blot</li><li>ELISA</li><li>Activity assays</li></ul><h4><strong>Advantages of Magnetic Bead-Based Workflows</strong></h4><p>Magnetic bead-based purification offers several key benefits:</p><h4><strong>Speed and Simplicity</strong></h4><ul><li>No centrifugation required</li><li>No complex instrumentation needed</li></ul><h4><strong>Improved Reproducibility</strong></h4><ul><li>Consistent magnetic separation</li><li>Reduced variability between runs</li></ul><h4><strong>Reduced Sample Loss</strong></h4><ul><li>Fewer transfer steps</li><li>Suitable for small or scarce samples</li></ul><h4><strong>Scalability and Throughput</strong></h4><ul><li>Compatible with automation</li><li>Supports microplate formats:<ul><li>96-well plates</li><li>384-well plates</li></ul></li></ul><h3><strong>Biozen™ Magnetic Beads Features</strong></h3><p>Phenomenex <strong>Biozen™ magnetic beads</strong> incorporate several design features:</p><ul><li><strong>Hydrophilic co-polymer surface</strong><ul><li>Reduces non-specific hydrophobic interactions</li></ul></li><li><strong>Biotinylated BSA spacer</strong><ul><li>Acts as a linker to streptavidin</li><li>Helps orient capture ligands</li></ul></li><li><strong>Monodispersed capture ligands</strong><ul><li>Optimized binding capacity</li></ul></li></ul><p>These features contribute to:</p><ul><li>Reduced non-specific binding</li><li>Improved capture consistency</li><li>Cleaner eluates</li></ul><h3><strong>When to Use Magnetic Beads</strong></h3><p>Magnetic bead-based purification is particularly suitable when:</p><ul><li>Sample volumes are small</li><li>Fast turnaround is required</li><li>Minimal equipment is preferred</li><li>High-throughput workflows are needed</li></ul><h3><strong>Conclusion</strong></h3><p>Magnetic bead-based protein purification simplifies traditional workflows by eliminating centrifugation and reducing complexity. Through selective capture and efficient magnetic separation, it enables faster processing, improved reproducibility, and compatibility with high-throughput and automated systems.</p>

Magnetic Bead-Based Protein Purification: A Faster and More Efficient Workflow

Microplastics and Nanomaterials: Understanding Emerging Contaminants in Environmental Testing

Article

Application

Academy

Environment

Video

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories.

Phenomenex

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Separation Science

Agilent Technologies

Thermo Fisher Scientific

Restek Corporation

SCIEX

Waters Corporation

<p><strong>As population grows, demand for food consumption and global trade in the food industry has also increased. Hundreds of pesticides are routinely used for crop protection across the globe, traces of pesticides left in treated commodities are called “residues”.</strong></p>
<p>Regulation (EC) No 396/2005 sets maximum residue levels of pesticides in or on food and feed and is under constant revision as shown by the recent amendment EU 2021/155, published February 9th 2021. A growing target list of pesticides in complex matrices, and the need for low limits of detection, bring various challenges to testing laboratories.</p>
<h3><strong>Pesticide Thursdays - A Waters&#39; 3-episode webinar series</strong></h3>
<h4><strong>Episode 3 - Polar Pesticides analysis in challenging food matrices</strong></h4>
<p>Routine analysis of anionic polar pesticides is challenging but has become a requirement for many food laboratories. With the move to a generic and simplified extraction techniques, the demand for lower limits of quantification for these negative ionization analytes has been developed.</p>
<p>In this webinar, our aim is to focus on routine analysis of anionic polar pesticides in complex matrices such as flour.</p>
<p>Join us for the Pesticide Thursdays webinar series and learn more about Waters turn-key solutions developed to tackle pesticide residue analysis in food and feed.</p>
<p>We are looking forward to discussing these topics with you.</p>
<p>Your Analytical Foodies Team</p>
<blockquote>
<p><strong>Presenter:</strong> Benjamin Wuyts (Senior Solution Support Specialist, Waters Corporation)</p>
</blockquote>
<blockquote>
<p>Benjamin initially joined Waters as an application chemist working in the Belgian demo lab, performing liquid chromatography-mass spectrometry demonstrations, support and training. In 2016 Benjamin became a European application chemist focusing on projects to support emerging applications. Benjamin has been focused over several years in establishing the Waters solution to the analysis of polar anionic pesticides, utilising novel column phases and LC-MS/MS technologies.</p>
</blockquote>


Waters Corporation: Polar Pesticides analysis in challenging food matrices - Pesticide Thursdays Webinar Series

Polar Pesticides analysis in challenging food matrices - Pesticide Thursdays Webinar Series

In this webinar, our aim is to focus on routine analysis of anionic polar pesticides in complex matrices such as flour.

Polar Pesticides analysis in challenging food matrices

<p>Traditional analytical workflows often involve sample preparation techniques requiring the use of large volumes of raw samples and organic solvents. The goal is to drive up recovery and sensitivity as it pertains to obtaining low levels of analyte detection.</p>
<p>Modern SPE technology has emerged to minimize sample and solvent consumption, while providing analytical sensitivity that is comparable to traditional workflows. The Biotage® MIKRO plate incorporates a common 96-well plate format for high throughput analysis and a robust, loosely packed 2 mg polymeric sorbent for the extraction of a variety of analytes.</p>
<p>Presented here is a brief overview of common but essential workflows in a microelution format, fully automated on the Biotage® Extrahera LV-200 sample preparation instrument. Workflows are simple, cost effective, and include discussions of drugs of abuse, steroids, catecholamines, and metanephrines.</p>
<h5>Attendees will:</h5>
<ul>
<li><strong>learn the unique differences between microelution and conventional SPE</strong></li>
<li><strong>better understand the application benefits of Mikro SPE</strong></li>
<li><strong>learn how to troubleshoot to improve analyte recovery</strong></li>
<li><strong>gain a direct comparison of the performance of traditional SPE workflow vs Mikro SPE automated workflow</strong></li>
</ul>
<blockquote>
<p><strong>Presenter:</strong> Amber Cain (Application Scientist, Biotage)</p>
</blockquote>
<blockquote>
<p>Amber has 10 years of experience, largely involved in contract research organization work from bioanalytical pharmaceutical testing and metabolomics. She has extensive experience with SPE and other sample preparation techniques as well as LC-MS/MS.</p>
</blockquote>


SeparationScience: The Might of MIKRO: Rethinking Routine Analytical Workflows through Volume Reduction and Solvent Consumption

The Might of MIKRO: Rethinking Routine Analytical Workflows through Volume Reduction and Solvent Consumption

An overview of common but essential workflows in a microelution format, fully automated on the Biotage® Extrahera LV-200 sample preparation instrument.

Analytical Workf. - Volume Reduction and Solvent Consumption

<p><strong>During this webinar we will take a look at some of the latest trends and hot topics that are being observed within regulated laboratories. We will also discuss various processes that you need to implement in order to remain compliant with the latest regulatory guidance and minimize your inspection risk.</strong></p>
<h5>Specific topics that will be covered will include:</h5>
<ul>
<li><p><strong>Custom Analytical Instrument Qualification (AIQ) based on User Requirement Specifications (URS)</strong></p>
</li>
<li><p><strong>Repair Qualification (RQ)</strong></p>
</li>
<li><p><strong>Hidden costs of Self-Qualification</strong></p>
</li>
<li><p><strong>Computer System Validation (CSV)</strong></p>
</li>
</ul>
<blockquote>
<p><strong>Presenter:</strong> Garry Wright (European Laboratory Compliance Specialist, Agilent Technologies)</p>
</blockquote>
<blockquote>
<p>Garry Wright is the European Laboratory Compliance Specialist for Agilent Technologies and a member of the Agilent Compliance Council. Garry worked in Regulated Pharmaceutical industry for 20 years prior to joining Agilent.</p>
</blockquote>
<blockquote>
<p>His industrial experience focussed on development and implementation of Quality Management Systems, GMP training and Compliance Auditing. Garry’s role within Agilent is to provide Compliance Consulting services to Agilent and our customer network.</p>
</blockquote>
<blockquote>
<p>Garry has presented topics relating to Regulatory Compliance, Data Integrity and Instrument Qualification at a variety of Compliance forums over the last 7 years since joining Agilent.</p>
</blockquote>


Agilent Technologies: How to Minimize Compliance Risk in Regulated Laboratories

How to Minimize Compliance Risk in Regulated Laboratories

During this webinar we will take a look at some of the latest trends and hot topics that are being observed within regulated laboratories.

<p><strong>The HPLC instrument has been at the heart of many analytical laboratories for several decades now. Quite often analysts may be introduced to the concept of chromatography through the course of study, but it’s much less likely that the mechanics of the system will have been explored in detail. Because of this, it can be a bit daunting approaching problem solving with these instruments.</strong></p>
<p>In this presentation, we’ll be walking you through an overview of the processes involved with basic HPLC instrumentation. From there we’ll examine in a greater depth how each component of a HPLC system comes together to provide the analysis you may be looking for, looking at the finer mechanical details of what is taking place, and offering tips along the way to keep your system running smoother for longer.</p>
<h5>This webinar aims to:</h5>
<ul>
<li><strong>Provide a general overview of what an HPLC Instrument is</strong></li>
<li><strong>Look in greater depth at individual sections of the HPLC instrument to describe how they function</strong></li>
<li><strong>Offer some advice on how to look after your instrument to keep it running well for longer</strong></li>
</ul>


Restek: LC Hardware Troubleshooting part 1

LC Hardware Troubleshooting part 1

In this presentation, we’ll be walking you through an overview of the processes involved with basic HPLC instrumentation.

<p><strong>SCIEX has been at the forefront of bringing innovative MS technologies to its customers and creating platforms to share the expertise of our customers. SCIEX aims to make you more productive with our end-to-end LC-MS/MS solutions and this November we are organizing a virtual Pharma Conclave.</strong></p>
<h5>Who should attend:</h5>
<p>Individuals with an interest in</p>
<ul>
<li>Impurity profiling strategies for APIs and drug products</li>
<li>Pharmaceutical – regulations, methods, and challenges</li>
<li>E&amp;L testing and regulations</li>
<li>Cleaning validation</li>
<li>Pharma regulatory landscape in India and the global context</li>
</ul>
<h5><strong>Agenda: Day 1 - November 24, 2022</strong></h5>
<ul>
<li>10.30 - 10.35 a.m. Introduction to SCIEX </li>
<li>10.35 - 11.00 a.m. Nitroso impurities - current regulatory updates, challenges, and suggested solutions</li>
<li>11:00 - 11:25 a.m. Nitrosamines, NDSRIs and azido impurities as cohorts of concern in pharmaceuticals</li>
<li>11:25 - 11.50 a.m. Challenges in quantifying NDSRIs in pharmaceutical drug products</li>
<li>11.50 - 12.30 p.m. Panel discussion on nitroso impurities - need gap analysis and directions for the Indian pharma industry</li>
</ul>
<p> </p>
<p><strong>Presenter:</strong> Dr. BM Rao (Partner &amp; CEO at QDOT Associates)</p>
<p><strong>Presenter:</strong> Dr. Saranjit Singh (Ex-Dean and HOD, Dept. of Pharmaceutical Analysis, NIPER, Mohali)</p>
<p><strong>Presenter:</strong> Dr. Harsha K N (Head - Analytical Characterization at Shilpa Medicare LTD, Dabaspet, Bangalore)</p>
<p><strong>Presenter:</strong> Shivkumar Vishwanathan (Director and V.P Marketing at GVS Cibatech Pvt Ltd, Mumbai)</p>
<p><strong>Presenter:</strong> Dr. Dama Venugopal Rao (Lead-Structural Characterisation and Analytical Expert- complex injectables at Dr. Reddy&#39;s Laboratories)</p>


SCIEX: SCIEX Pharma Conclave 2022 (Day 1)

SCIEX Pharma Conclave 2022 (Day 1)

SCIEX aims to make you more productive with our end-to-end LC-MS/MS solutions and this November we are organizing a virtual Pharma Conclave.

<p><strong>SCIEX has been at the forefront of bringing innovative MS technologies to its customers and creating platforms to share the expertise of our customers. SCIEX aims to make you more productive with our end-to-end LC-MS/MS solutions and this November we are organizing a virtual Pharma Conclave.</strong></p>
<h5>Who should attend:</h5>
<p>Individuals with an interest in</p>
<ul>
<li>Impurity profiling strategies for APIs and drug products</li>
<li>Pharmaceutical – regulations, methods, and challenges</li>
<li>E&amp;L testing and regulations</li>
<li>Cleaning validation</li>
<li>Pharma regulatory landscape in India and the global context</li>
</ul>
<h5><strong>Agenda: Day 1 - November 24, 2022</strong></h5>
<ul>
<li>10.30 - 10.35 a.m. Welcome note</li>
<li>10.35 - 11.00 a.m. Regulatory landscape for extractables and leachables testing</li>
<li>11:00 - 11:25 a.m. Challenges in extractables and leachables (E&amp;L) study in pharmaceutical</li>
<li>11:25 - 11.50 a.m. Challenges in equipment cleaning and contamination control of nitrosamines</li>
<li>11.50 - 12.30 p.m. Panel discussion on E&amp;L regulatory -  landscape, guidelines on pharmaceutical packaging systems</li>
</ul>
<p><strong>Presenter:</strong> Dr. BM Rao (Partner &amp; CEO at QDOT Associates)</p>
<p><strong>Presenter:</strong> Dr. Saranjit Singh (Ex-Dean and HOD, Dept. of Pharmaceutical Analysis, NIPER, Mohali)</p>
<p><strong>Presenter:</strong> Dr. Harsha K N (Head - Analytical Characterization at Shilpa Medicare LTD, Dabaspet, Bangalore)</p>
<p><strong>Presenter:</strong> Shivkumar Vishwanathan (Director and V.P Marketing at GVS Cibatech Pvt Ltd, Mumbai)</p>
<p><strong>Presenter:</strong> Dr. Dama Venugopal Rao (Lead-Structural Characterisation and Analytical Expert- complex injectables at Dr. Reddy&#39;s Laboratories)</p>


SCIEX: SCIEX Pharma Conclave 2022 (Day 2)

SCIEX Pharma Conclave 2022 (Day 2)

<p><strong>The analysis of mineral oil saturated hydrocarbons (MOSH) and mineral oil aromatic hydrocarbons (MOAH) in food samples is a challenging application. Don´t miss this opportunity to ask our experts all your questions regarding the fully automated LC/GC workflow for MOAH/MOAH analysis.</strong></p>
<p>We start with a brief introduction where we talk about upcoming changes in the legal requirements for MOSH/MOAH analysis. The remaining time is fully dedicated to your questions.</p>
<p>There are three ways to submit your questions:</p>
<ul>
<li>Fill out the box on the webinar registration form</li>
<li>For more detailed questions, you can email us at: analyze.eu@thermofisher.com</li>
<li>Ask your questions on the day using the chat function during the live session</li>
</ul>
<p>Of course you are welcome to join even if you don´t have a specific question, so you can pick up useful information and build up expertise.</p>
<blockquote>
<p><strong>Presenter:</strong> Jeroen Weyts (SampleQ Analytical Support GC-MS, Thermo Fisher Scientific)</p>
</blockquote>
<blockquote>
<p><strong>Presenter:</strong> Jorn Hofsteenge (SampleQ Analytical Support GC)</p>
</blockquote>
<blockquote>
<p><strong>Presenter:</strong> Inge de Dobbeleer (Sample Q Account Manager)</p>
</blockquote>
<blockquote>
<p><strong>Presenter:</strong> Petra Gerhards (Regional Marketing Manager for GC &amp; GC-MS, EMEA, Thermo Fisher Scientific)</p>
</blockquote>


Thermo Fisher Scientific: Ask-the-experts session on MOSH/MOAH analysis

Ask-the-experts session on MOSH/MOAH analysis

Don´t miss this opportunity to ask our experts all your questions regarding the fully automated LC/GC workflow for MOAH/MOAH analysis.

<p><strong>How do you know if your peak is “pure”? How do you know if your sample conforms to your gold standard? OpenLab CDS provides the tools to answer these questions. This seminar will show you how.</strong></p>
<blockquote>
<p><strong>Presenter:</strong> Richard Mutkoski (Laboratory Informatics Application Engineer, Agilent Technologies, Inc.)</p>
</blockquote>
<blockquote>
<p>Richard Mutkoski has been a field representative for over 27 years for both hardware and software. In his current role as an Informatics Application Engineer, Rich presents technical solutions of the OpenLab suite of products to customers worldwide. Prior to his tenure at Agilent Rich spent 15 years in a variety of Pharma QA/QC and R&amp;D positions providing him a unique understanding of those workflows, bottlenecks and challenges.</p>
</blockquote>


Agilent Technologies: Save Time Using the New Integration Optimizer in OpenLab CDS

Save Time Using the New Integration Optimizer in OpenLab CDS

How do you know if your peak is “pure”? How do you know if your sample conforms to your gold standard?

<p><strong>AQbD or Analytical Quality by Design is an approach to analytical method development that “starts with the end in mind”.</strong></p>
<p>Regulators welcome this science and risk-based approach as described in several guidelines from ICH, USP, and BP. Using the preferred language of regulators when filling applications for both small and large molecules, synthetic or biological drugs can significantly reduce the time-to-market.</p>
<p>Learn about general concepts and approaches to AQbD that are outlined in the upcoming ICH Q14 and USP &lt;1220&gt; chapters and how industry leaders and Waters are tackling these exciting workflows guaranteed to reduce risk and produce robust methods across your organization. </p>
<p>Join us on Tuesday, November 29 and hear from experts in the Pharma arena to receive an update on the guidance, and the impact for the industry, an example for the phase-appropriate implementation of AQbD method development and a how to mitigate risk using the MaxPeak High Performance Surface. </p>
<p>Followed by a live panel discussion with all the speakers. So have your questions ready!</p>
<h3><strong>Confirmed Speakers on 29 Nov:</strong></h3>
<h4><strong>Analytical Procedure Development &amp; Validation – ICH Q14, ICH Q2 (R2) &amp; USP &lt;1220&gt;</strong></h4>
<p> </p>
<blockquote>
<p><strong>Presenter:</strong> Phil Borman (Director and Senior Fellow, GSK)</p>
</blockquote>
<blockquote>
<p>Phil Bormanis a fellow of the Royal Society of Chemistry with over 26 years of experience in the pharmaceutical industry having obtained a Masters in Chemistry from Manchester University, a Masters in Applied Statistics from De Montfort (Leicester) University and a Doctorate in Sciences for his work in pioneering and developing QbD approaches for analytical procedures (also from De Montfort University).</p>
</blockquote>
<blockquote>
<p>Phil is currently a Director and Senior Fellow at GlaxoSmithKline where he is accountable for the ongoing development and implementation of Quality by Design. Phil pioneered the adaptation of QbD principles to Analytical procedures and has published widely in the field of Analytical Chemistry. He currently co-leads the EFPIA ICH Q2(R2)/Q14 support team as well as being vice-chair of the USP Measurement and Data Quality Expert Committee and member of the BP (MHRA) Analytical Quality by Design Working party.</p>
</blockquote>
<h4><strong>Development of analytical methods based on the aQbD principles to support pharmaceutical development, commercialization and supply</strong></h4>
<blockquote>
<p><strong>Presenter:</strong> Jinjian Zheng (Sr. Principal Scientist, Merck)</p>
</blockquote>
<blockquote>
<p>Dr. Jinjian Zheng earned his Ph.D. degree from The University of Tokyo in 1999, and joined Ames-Laboratory, Iowa State University as a postdoc in 2000. He joined Schering-Plough/ Merck in 2003, and is currently a Sr. Principal Scientist at Analytical Chemistry in Development and Supply – Analytical Commercialization Technology.</p>
</blockquote>
<blockquote>
<p>During his tenure at Merck, Jinjian has served on different roles within Merck across development, commercialization and supply areas. He has established himself as a chromatography SME, and has been promoting aQbD method development at Merck using advanced tools such as chromatography simulation and DOE experimentation.</p>
</blockquote>
<blockquote>
<p>Jinjian has published 20+ articles in peer reviewed journals, and has given numerous presentations on aQbD method development. He is currently leading the analytical development efforts at Merck to support nitrosamine risk assessment and testing.</p>
</blockquote>
<h4><strong>Mitigating Risks Associated with Undesired Analyte-Metal Interactions</strong></h4>
<blockquote>
<p><strong>Presenter:</strong> Pankaj Aggarwal (Associate Principal Scientist, Merck)</p>
</blockquote>
<blockquote>
<p>Pankaj has a PhD in analytical chemistry with over 7+ years of pharmaceutical industry supporting API and DP development across different modalities. Currently, He is working as Associate Principal Scientist at Merck and a scientific supervisor implementing predictive and digital solution for workflow optimization leading to operation excellence and accelerated drug development. Pankaj is passionate about lab automation/digital data analytics and helping teams applying in-silico tools to fundamentally understand LC method performance.</p>
</blockquote>
<h4><strong>Moderator for the Event Day 1</strong></h4>
<blockquote>
<p><strong>Presenter:</strong> Fadi Alkhateeb (Senior Scientist, Waters Corporation)</p>
</blockquote>
<blockquote>
<p>Dr. Fadi Alkhateeb is a Senior Scientist in the Scientific Operations Department at Waters Corporation HeadQuarters in Milford, MA USA. He joined Waters in 2017 and since then he has been mainly focusing on exploring various approaches for analytical method development for pharmaceutical drugs. Prior to joining Waters, he was a postdoctoral fellow at the University of Calgary (Calgary, AB, Canada), where he did research at Alberta Sulphur Research, one of North America&#39;s leading Sulphur research institutes.</p>
</blockquote>
<blockquote>
<p>He received his PhD from the University of Calgary, focusing on the development of novel, rapid separation and sample preparation techniques for the analysis of a wide range of chemical compounds. Dr. Alkhateeb published several peer-reviewed articles in top analytical journals.</p>
</blockquote>


AQbD Symposium - Day 1 - Concepts and Approaches for Enhanced Method Development

An update on the guidance, and the impact, the phase-appropriate implementation of AQbD MD and the MaxPeak High Performance Surface. 

Concepts and Approaches for Enhanced Method Development

<h3><strong>Agenda</strong></h3>
<ul>
<li><p>9:55 Welcome and introduction</p>
</li>
<li><p><strong>10:00 SCIEX 7500 system hardware overview</strong></p>
</li>
<li><p><strong>10:30 SCIEX OS software overview — acquisition</strong></p>
</li>
<li><p><strong>11:00 Lab session part 1 – set up method and data acquisition (pre-recorded)</strong></p>
</li>
<li><p>11:45 Break</p>
</li>
<li><p><strong>12:15 Lab session part 2 - data review (pre-recorded)</strong></p>
</li>
<li><p><strong>13:00 SCIEX OS software overview - data processing</strong></p>
</li>
<li><p><strong>13:30 Question and answer</strong></p>
</li>
<li><p>14:00 Closing</p>
</li>
</ul>
<h3><strong>Your hosts for the day</strong></h3>
<h5>Dr Jianru Stahl-Zeng (Sr Technical Marketing Manager)</h5>
<h5>Jack Steed (Technical Specialist)</h5>


SCIEX: SCIEX 7500 System Virtual Tech Day

SCIEX 7500 System Virtual Tech Day

You will learn and experiment from our experts on how to acquire, review and process your data using SCIEX OS software and the SCIEX 7500 system.